Capital Impact Advisors’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-12,572
| Closed | -$531K | – | 17 |
|
|
2024
Q2 | $531K | Sell |
12,572
-8,707
| -41% | -$368K | 1.49% | 40 |
|
|
2024
Q1 | $1.47M | Buy |
21,279
+12,585
| +145% | +$869K | 1.91% | 13 |
|
|
2023
Q4 | $643K | Buy |
8,694
+4,584
| +112% | +$339K | 0.85% | 60 |
|
|
2023
Q3 | $280K | Hold |
4,110
| – | – | 0.47% | 86 |
|
|
2023
Q2 | $386K | Sell |
4,110
-757
| -16% | -$71.1K | 0.42% | 113 |
|
|
2023
Q1 | $330K | Sell |
4,867
-1,609
| -25% | -$109K | 0.4% | 116 |
|
|
2022
Q4 | $321K | Buy |
6,476
+1,043
| +19% | +$51.6K | 0.31% | 140 |
|
|
2022
Q3 | $201K | Buy |
5,433
+2,612
| +93% | +$96.6K | 0.2% | 180 |
|
|
2022
Q2 | $111K | Sell |
2,821
-4,052
| -59% | -$159K | 0.1% | 217 |
|
|
2022
Q1 | $481K | Buy |
+6,873
| New | +$481K | 0.35% | 136 |
|
|
2021
Q4 | – | Sell |
-13,400
| Closed | -$1.28M | – | 112 |
|
|
2021
Q3 | $1.28M | Sell |
13,400
-33,988
| -72% | -$3.24M | 0.51% | 84 |
|
|
2021
Q2 | $5.4M | Buy |
47,388
+37,854
| +397% | +$4.31M | 1.74% | 7 |
|
|
2021
Q1 | $1.26M | Sell |
9,534
-60,168
| -86% | -$7.93M | 0.44% | 81 |
|
|
2020
Q4 | $9.24M | Buy |
69,702
+5,000
| +8% | +$662K | 2.27% | 4 |
|
|
2020
Q3 | $6.6M | Buy |
+64,702
| New | +$6.6M | 1.95% | 8 |
|